PL2528930T3 - 4`-azydonukleozydy jako związki przeciw hcv - Google Patents
4`-azydonukleozydy jako związki przeciw hcvInfo
- Publication number
- PL2528930T3 PL2528930T3 PL11701107T PL11701107T PL2528930T3 PL 2528930 T3 PL2528930 T3 PL 2528930T3 PL 11701107 T PL11701107 T PL 11701107T PL 11701107 T PL11701107 T PL 11701107T PL 2528930 T3 PL2528930 T3 PL 2528930T3
- Authority
- PL
- Poland
- Prior art keywords
- nucleosides
- azido
- hcv compounds
- hcv
- compounds
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 title 1
- 239000002777 nucleoside Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
- C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
- C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
- C07H19/06—Pyrimidine radicals
- C07H19/067—Pyrimidine radicals with ribosyl as the saccharide radical
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
- A61K31/7052—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides
- A61K31/706—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom
- A61K31/7064—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines
- A61K31/7068—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid
- A61K31/7072—Compounds having saccharide radicals and heterocyclic rings having nitrogen as a ring hetero atom, e.g. nucleosides, nucleotides containing six-membered rings with nitrogen as a ring hetero atom containing condensed or non-condensed pyrimidines having oxo groups directly attached to the pyrimidine ring, e.g. cytidine, cytidylic acid having two oxo groups directly attached to the pyrimidine ring, e.g. uridine, uridylic acid, thymidine, zidovudine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Communicable Diseases (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Gastroenterology & Hepatology (AREA)
- Oncology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29922910P | 2010-01-28 | 2010-01-28 | |
| PCT/EP2011/050971 WO2011092158A1 (en) | 2010-01-28 | 2011-01-25 | 4 ' - azido - nucleosides as anti - hcv compunds |
| EP11701107.2A EP2528930B1 (en) | 2010-01-28 | 2011-01-25 | 4'-azido-nucleosides as anti-hcv compounds |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL2528930T3 true PL2528930T3 (pl) | 2014-03-31 |
Family
ID=43587111
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL11701107T PL2528930T3 (pl) | 2010-01-28 | 2011-01-25 | 4`-azydonukleozydy jako związki przeciw hcv |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US8236779B2 (pl) |
| EP (1) | EP2528930B1 (pl) |
| JP (1) | JP5675849B2 (pl) |
| KR (1) | KR101384389B1 (pl) |
| CN (1) | CN102725303B (pl) |
| BR (1) | BR112012015951A2 (pl) |
| CA (1) | CA2784330C (pl) |
| DK (1) | DK2528930T3 (pl) |
| ES (1) | ES2437933T3 (pl) |
| MX (1) | MX337050B (pl) |
| PL (1) | PL2528930T3 (pl) |
| PT (1) | PT2528930E (pl) |
| RU (1) | RU2556991C2 (pl) |
| TW (1) | TW201141488A (pl) |
| WO (1) | WO2011092158A1 (pl) |
Families Citing this family (25)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP2619215B1 (en) * | 2010-09-22 | 2018-09-05 | Alios Biopharma, Inc. | Azido nucleosides and nucleotide analogs |
| US9243025B2 (en) | 2011-03-31 | 2016-01-26 | Idenix Pharmaceuticals, Llc | Compounds and pharmaceutical compositions for the treatment of viral infections |
| AR088441A1 (es) | 2011-09-12 | 2014-06-11 | Idenix Pharmaceuticals Inc | Compuestos de carboniloximetilfosforamidato sustituido y composiciones farmaceuticas para el tratamiento de infecciones virales |
| US8507460B2 (en) | 2011-10-14 | 2013-08-13 | Idenix Pharmaceuticals, Inc. | Substituted 3′,5′-cyclic phosphates of purine nucleotide compounds and pharmaceutical compositions for the treatment of viral infections |
| US9296778B2 (en) | 2012-05-22 | 2016-03-29 | Idenix Pharmaceuticals, Inc. | 3′,5′-cyclic phosphate prodrugs for HCV infection |
| JP6165848B2 (ja) | 2012-05-22 | 2017-07-19 | イデニク ファーマシューティカルズ エルエルシー | 肝疾患のためのd−アミノ酸化合物 |
| WO2013177188A1 (en) | 2012-05-22 | 2013-11-28 | Idenix Pharmaceuticals, Inc. | 3',5'-cyclic phosphoramidate prodrugs for hcv infection |
| MX2014014323A (es) | 2012-05-25 | 2015-02-12 | Janssen R & D Ireland | Nucleosidos de espirooxetano de uracilo. |
| WO2014052638A1 (en) | 2012-09-27 | 2014-04-03 | Idenix Pharmaceuticals, Inc. | Esters and malonates of sate prodrugs |
| EP2906579B1 (en) | 2012-10-08 | 2018-04-18 | Idenix Pharmaceuticals LLC. | 2'-chloro nucleoside analogs for hcv infection |
| US10723754B2 (en) | 2012-10-22 | 2020-07-28 | Idenix Pharmaceuticals Llc | 2′,4′-bridged nucleosides for HCV infection |
| EP2935304A1 (en) | 2012-12-19 | 2015-10-28 | IDENIX Pharmaceuticals, Inc. | 4'-fluoro nucleosides for the treatment of hcv |
| WO2014137930A1 (en) | 2013-03-04 | 2014-09-12 | Idenix Pharmaceuticals, Inc. | Thiophosphate nucleosides for the treatment of hcv |
| WO2014137926A1 (en) | 2013-03-04 | 2014-09-12 | Idenix Pharmaceuticals, Inc. | 3'-deoxy nucleosides for the treatment of hcv |
| WO2014160484A1 (en) | 2013-03-13 | 2014-10-02 | Idenix Pharmaceuticals, Inc. | Amino acid phosphoramidate pronucleotides of 2'-cyano, azido and amino nucleosides for the treatment of hcv |
| EP2981542B1 (en) | 2013-04-01 | 2021-09-15 | Idenix Pharmaceuticals LLC | 2',4'-fluoro nucleosides for the treatment of hcv |
| US10005779B2 (en) | 2013-06-05 | 2018-06-26 | Idenix Pharmaceuticals Llc | 1′,4′-thio nucleosides for the treatment of HCV |
| WO2015017713A1 (en) | 2013-08-01 | 2015-02-05 | Idenix Pharmaceuticals, Inc. | D-amino acid phosphoramidate pronucleotides of halogeno pyrimidine compounds for liver disease |
| US10202411B2 (en) | 2014-04-16 | 2019-02-12 | Idenix Pharmaceuticals Llc | 3′-substituted methyl or alkynyl nucleosides nucleotides for the treatment of HCV |
| SI3154526T1 (sl) * | 2014-06-13 | 2019-08-30 | Ratiopharm Gmbh | Trdne oblike sofosbuvira |
| JP7381190B2 (ja) | 2014-12-26 | 2023-11-15 | エモリー・ユニバーシテイ | N4-ヒドロキシシチジン及び誘導体並びにそれに関連する抗ウイルス用途 |
| US10448015B2 (en) * | 2015-06-16 | 2019-10-15 | Lg Electronics Inc. | Method and device for performing adaptive filtering according to block boundary |
| PT3706762T (pt) * | 2017-12-07 | 2024-12-05 | Univ Emory | N4-hidroxicitidina e derivados e utilizações antivirais relacionadas com os mesmos |
| US12274700B1 (en) | 2020-10-30 | 2025-04-15 | Accencio LLC | Methods of treating symptoms of coronavirus infection with RNA polymerase inhibitors |
| CN113880903B (zh) * | 2021-09-23 | 2024-07-02 | 厦门蔚嘉制药有限公司 | 莫那比拉韦的制备方法 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1964569A3 (en) * | 2000-04-13 | 2009-07-22 | Pharmasset, Inc. | 3'-or 2'-hydroxymethyl substituted nucleoside derivatives for treatment of viral infections |
| WO2002032920A2 (en) * | 2000-10-18 | 2002-04-25 | Pharmasset Limited | Modified nucleosides for treatment of viral infections and abnormal cellular proliferation |
| SK286630B6 (sk) * | 2001-01-22 | 2009-02-05 | Merck & Co., Inc. | Nukleozidové deriváty, farmaceutický prostriedok s ich obsahom a ich použitie |
| GB0114286D0 (en) * | 2001-06-12 | 2001-08-01 | Hoffmann La Roche | Nucleoside Derivatives |
| US20040063658A1 (en) * | 2002-05-06 | 2004-04-01 | Roberts Christopher Don | Nucleoside derivatives for treating hepatitis C virus infection |
| CN100351264C (zh) * | 2002-11-19 | 2007-11-28 | 霍夫曼-拉罗奇有限公司 | 抗病毒核苷衍生物 |
| TWI332507B (en) | 2002-11-19 | 2010-11-01 | Hoffmann La Roche | Antiviral nucleoside derivatives |
| PT1962808E (pt) * | 2005-12-14 | 2010-10-29 | Hoffmann La Roche | Formulação de precursor de fármaco para o hcv |
| US20090318380A1 (en) * | 2007-11-20 | 2009-12-24 | Pharmasset, Inc. | 2',4'-substituted nucleosides as antiviral agents |
| AR069740A1 (es) * | 2007-11-29 | 2010-02-17 | Metabasis Therapeutics Inc | Compuestos nucleosidos antivirales |
-
2011
- 2011-01-25 WO PCT/EP2011/050971 patent/WO2011092158A1/en not_active Ceased
- 2011-01-25 JP JP2012550415A patent/JP5675849B2/ja not_active Expired - Fee Related
- 2011-01-25 KR KR1020127022217A patent/KR101384389B1/ko not_active Expired - Fee Related
- 2011-01-25 RU RU2012136379/04A patent/RU2556991C2/ru not_active IP Right Cessation
- 2011-01-25 CA CA2784330A patent/CA2784330C/en not_active Expired - Fee Related
- 2011-01-25 BR BR112012015951A patent/BR112012015951A2/pt active Search and Examination
- 2011-01-25 TW TW100102705A patent/TW201141488A/zh unknown
- 2011-01-25 PT PT117011072T patent/PT2528930E/pt unknown
- 2011-01-25 ES ES11701107.2T patent/ES2437933T3/es active Active
- 2011-01-25 PL PL11701107T patent/PL2528930T3/pl unknown
- 2011-01-25 EP EP11701107.2A patent/EP2528930B1/en not_active Not-in-force
- 2011-01-25 CN CN201180007367.0A patent/CN102725303B/zh not_active Expired - Fee Related
- 2011-01-25 DK DK11701107.2T patent/DK2528930T3/da active
- 2011-01-25 MX MX2012008443A patent/MX337050B/es active IP Right Grant
- 2011-01-26 US US13/014,022 patent/US8236779B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| PT2528930E (pt) | 2013-11-26 |
| CA2784330A1 (en) | 2011-08-04 |
| EP2528930B1 (en) | 2013-10-30 |
| TW201141488A (en) | 2011-12-01 |
| ES2437933T3 (es) | 2014-01-15 |
| CN102725303A (zh) | 2012-10-10 |
| BR112012015951A2 (pt) | 2018-10-16 |
| MX337050B (es) | 2016-02-10 |
| KR20120110177A (ko) | 2012-10-09 |
| RU2556991C2 (ru) | 2015-07-20 |
| HK1176938A1 (en) | 2013-08-09 |
| JP5675849B2 (ja) | 2015-02-25 |
| MX2012008443A (es) | 2012-08-15 |
| EP2528930A1 (en) | 2012-12-05 |
| KR101384389B1 (ko) | 2014-04-10 |
| US8236779B2 (en) | 2012-08-07 |
| CA2784330C (en) | 2018-02-13 |
| DK2528930T3 (da) | 2013-11-11 |
| US20110150829A1 (en) | 2011-06-23 |
| JP2013518076A (ja) | 2013-05-20 |
| RU2012136379A (ru) | 2014-03-10 |
| WO2011092158A1 (en) | 2011-08-04 |
| CN102725303B (zh) | 2015-05-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PL2528930T3 (pl) | 4`-azydonukleozydy jako związki przeciw hcv | |
| ZA201108962B (en) | Substituted 1-cyanoethylheterocyclylcarboxamide compounds 750 | |
| GB0900404D0 (en) | New compounds 4 | |
| ZA201208013B (en) | " selp-standing comtainer " | |
| GB0912946D0 (en) | New compounds 5 | |
| GB201011831D0 (en) | New compounds 5 | |
| GB201009801D0 (en) | Compounds 950 | |
| GB201000655D0 (en) | New compounds 2 | |
| GB201009803D0 (en) | Compounds 814 | |
| GB201012790D0 (en) | Novel compounds 1 | |
| GB201012788D0 (en) | Novel compounds 11 | |
| GB201010529D0 (en) | "Tapease" | |
| GB201005408D0 (en) | "Speedlight" | |
| GB201009178D0 (en) | New compounds 2 | |
| GB201000653D0 (en) | New compounds 3 | |
| GB201009180D0 (en) | New compounds 1 | |
| GB201008194D0 (en) | No movement alarm - "Grandown" | |
| GB201018463D0 (en) | B'doosh | |
| GB201019720D0 (en) | Corcost- T 1 T | |
| GB201003793D0 (en) | Georobic 2 | |
| GB201008294D0 (en) | Ecomodule 600 | |
| GB201008318D0 (en) | Tidemill 1 | |
| GB201017776D0 (en) | Yota 201010 | |
| GB201018890D0 (en) | Corcost 2222 | |
| GB201003790D0 (en) | Georobic 1 |